ARTICLE 1 - FUNDAMENTAL LEASE PROVISIONSLease Agreement • May 19th, 2015 • ProNAi Therapeutics Inc • Pharmaceutical preparations • Michigan
LICENSE PAYMENT AGREEMENTLicense Payment Agreement • May 19th, 2015 • ProNAi Therapeutics Inc • Pharmaceutical preparations
THIS LICENSE PAYMENT AGREEMENT (this “Agreement”) is made effective as of April 14, 2014 (the “Effective Date”), by and among Novosom Verwaltungs GmbH, a German corporation with a corporate address of Weinbergweg 22, 06120 Halle, Germany (“Novosom”), and ProNAi Therapeutics, Inc., a Delaware corporation, with a corporate address of 46701 Commerce Center Drive, Plymouth, MI 48170 (“ProNAi”). ProNAi and Novosom are collectively referred to herein as the “Parties” and each of them as a “Party.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 19th, 2015 • ProNAi Therapeutics Inc • Pharmaceutical preparations • Delaware
For clarity each of the above milestone payments shall be paid only once for a particular Licensed Product, regardless if any such Milestone Event is achieved more than once, [***]. Further, if a particular Licensed Product achieves a particular Milestone Event under subclause (i) of the above table without having achieved a previous Milestone Event in such subclause (i), then such previous Milestone Event shall be deemed also achieved, and the Milestone Payment associated with such Milestone Event shall then be paid with the achievement of the subsequent
SECOND LICENSE AMENDMENT AND CONSENT TO TERMINATIONSecond License Amendment and Consent to Termination • May 19th, 2015 • ProNAi Therapeutics Inc • Pharmaceutical preparations
This Amendment and Agreement (“Amendment”), dated April 14, 2014 (the “Effective Date”), is made by and among Marina Biotech, Inc., a Delaware corporation with a place of business at 7 Times Square, 40th Floor, New York, NY 10028, Attention: Stephen M. Goodman (“Marina”), ProNAi Therapeutics, Inc., a Delaware corporation, with a corporate address of 46701 Commerce Center Drive, Plymouth, MI 48107 (“ProNAi”).
